Oncogenic NRAS rapidly and efficiently induces CMML- and AML-like diseases in mice
Open Access
- 1 October 2006
- journal article
- Published by American Society of Hematology in Blood
- Vol. 108 (7), 2349-2357
- https://doi.org/10.1182/blood-2004-08-009498
Abstract
Activating mutations in RAS, predominantly NRAS, are common in myeloid malignancies. Previous studies in animal models have shown that oncogenic NRAS is unable to induce myeloid malignancies effectively, and it was suggested that oncogenic NRAS might only act as a secondary mutation in leukemogenesis. In this study, we examined the leukemogenicity of NRAS using an improved mouse bone marrow transduction and transplantation model. We found that oncogenic NRAS rapidly and efficiently induced chronic myelomonocytic leukemia (CMML)– or acute myeloid leukemia (AML)– like disease in mice, indicating that mutated NRAS can function as an initiating oncogene in the induction of myeloid malignancies. In addition to CMML and AML, we found that NRAS induced mastocytosis in mice. This result indicates that activation of the RAS pathway also plays an important role in the pathogenesis of mastocytosis. The mouse model for NRAS leukemogenesis established here provides a system for further studying the molecular mechanisms in the pathogenesis of myeloid malignancies and for testing relevant therapies.This publication has 40 references indexed in Scilit:
- RAS mutation in acute myeloid leukemia is associated with distinct cytogenetic subgroups but does not influence outcome in patients younger than 60 yearsBlood, 2005
- Repressible transgenic model of NRAS oncogene–driven mast cell disease in the mouseBlood, 2005
- Renewing the conspiracy theory debate: does Raf function alone to mediate Ras oncogenesis?Trends in Cell Biology, 2004
- Species- and cell type-specific requirements for cellular transformationCancer Cell, 2004
- The molecular mechanism of chronic myelogenous leukemia and its therapeutic implications: studies in a murine modelOncogene, 2002
- The World Health Organization (WHO) classification of the myeloid neoplasmsBlood, 2002
- Dissecting the Molecular Mechanism of Chronic Myelogenous Leukemia Using Murine ModelsLeukemia & Lymphoma, 2002
- Targeted Genomic Disruption of H-ras and N-ras, Individually or in Combination, Reveals the Dispensability of Both Loci for Mouse Growth and DevelopmentMolecular and Cellular Biology, 2001
- Mutations and Expression of the ras Family Genes in LeukemiasThe International Journal of Cell Cloning, 1996
- ras GENESAnnual Review of Biochemistry, 1987